Nobody else has THE answer for COVID, nobody else has a good answer for HIV, there's some cancer treatments, depending on type, but who has an answer for handling CTC's? Autoimmune disorders? (Crohns? Graves? Arthritis?). What's the answer for organ transplant rejections? OHM posted a comprehensive list of POTENTIAL indications... I have a feeling Leronlimab will show some efficacy in at least a couple:

https://investorshangout.com/post/view?id=5723002

Quote:

---

Posted On: 04/03/2020 6:44:11 AM

Posted By: ohm20
Leronlimab - Disease List

An incomplete list of potential treatments targets for leronlimab.

Alzheimer's
Asthma
Atherosclerosis
Atopic Dermatitis
Cancer
Coeliac Disease
Chronic Fatigue Syndrome
COPD
COVID-19 (and other corona viruses)
Crohn's Disease
Colitis
Dermatomyositis
Diabetes (type 1)
Duchenne Muscular Dystrophy (possibly other muscular dystrophys also)
Emphysema
Fibromyalgia
Grave’s Disease
Guillain-Barre Syndrome
GVHD
Hashimoto’s Thyroiditis
Hepatitis (autoimmune)
HIV
Idiopathic Pulmonary Fibrosis
Inflammatory Bowel Disease
Influenza (severe)
Lambert-Eaton Syndrome
Lupus
Multiple Sclerosis
Myasthenia Gravis
Myocarditis
NASH
Neurofibromatosis
Parkinson's Disease
Pemphigus
Pneumonia
Polymyositis
Post-Myocardial Infarction Syndrome
Psoriasis
Rheumatic Fever
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sickle Cell Disease (anti-inflammatory effect)
Sjogren’s Syndrome
Stroke
Tuberculosis
Vasculitis


Read More: https://investorshangout.com/post/view?id=572...z6KW2keb00

---

So what does Cytodyn need, indication-wise and time-wise, to be at $300 a share? What kind of multiple should it have? Because it's looking pretty doable to me. So 5.5 years is a bit soon, make it 6.5